Skip to main content

Ampac claims revolution in continuous processing

Following launch at a symposium in Boston in September, Ampac Fine Chemicals (AFC), an SK Pharmteco company, has announced the development of a new series of skid-based modules for continuous flow processes. These, it claims, will revolutionise the technique, closing the gap between benchtop development with microreactors and manufacturing scale.

SK Pharmteco to expand Irish campus

SK Pharmteco has announced a two-phase, $35 million investment to boost both capacity and capabilities at its SK Biotek subsidiary’s manufacturing plant at Swords, Dublin. This is due online in 2024, the campus’s 60th anniversary as a small molecule API manufacture, and will lead to a 50% total increase in capacity.

Subscribe to SK Biotek